Betamethasone is a long-acting corticosteroid with immunosuppressive and antiinflammatory properties. It can be used topically to manage inflammatory skin conditions such as eczema, and parenterally to manage several disease states including autoimmune disorders. Betamethasone has potent glucocorticoid activity and negligible mineralocorticoid activity.
As a member of the corticosteroid family, betamethasone is indicated for the treatment of several inflammatory conditions. As topical monotherapy, betamethasone is indicated to relieve pruritic and inflammatory symptoms of corticosteroid-responsive-dermatoses. Betamethasone can be used topically in combination with a vitamin D analog such as calcipotriene to treat plaque psoriasis. The corticosteroid is also available as an injectable suspension and can be used to manage a range of inflammatory conditions including endocrine disorders, gastrointestinal disorders, and rheumatic disorders among other conditions.
Sultan 2.Abdülhamid Han Training and Research Hospital, Istanbul, Eyalet/Yerleşke, Turkey
University Hospital of Patras, PAtras, Achaia, Greece
Rambam health care campus, Haifa, Israel
bioskin GmbH, Hamburg, Germany
Rothaar Studien GmbH, Berlin, Germany
Centrum for Endocrinology and Metabolism, Sahlgenska University Hospital, Gothenburg, Sweden
Lawson Health Research Institute, London, Ontario, Canada
Komali Garlapati, Hyderabad, Telangana, India
11562, Cairo, Egypt
CPCAD, Nice, Cedex, France
University of Texas Medical Branch in Galveston, Galveston, Texas, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.